Status:
NOT_YET_RECRUITING
Neuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America
Lead Sponsor:
Latin American Cooperative Oncology Group
Collaborating Sponsors:
Boehringer Ingelheim
Grupo Argentino de Investigación Clínica en Oncología
Conditions:
Neuroendocrine Carcinomas
Lung Neuroendocrine Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
This observational, retrospective study aims to understand the treatment patterns and outcomes of patients with pulmonary and extra-pulmonary neuroendocrine carcinomas (NEC) in Latin America (Brazil, ...
Detailed Description
Currently, there is a hypothesis that there is not enough evidence to fully understand the patient journey and accurately determine the clinical outcomes of neuroendocrine carcinomas (NEC) in Latin Am...
Eligibility Criteria
Inclusion
- ≥18 years old
- Diagnosed between August 2014 and August 2024 with one of the following:
- Extrapulmonary Neuroendocrine Carcinoma (EP-NEC)
- Large-cell neuroendocrine carcinoma (LCNEC) or mixed
- Small Cell Lung Cancer (SCLC) or mixed
- Adequate and accessible medical records for data collection
- Tumor block collected from 2014 onwards
Exclusion
- Patients with active, concurrent malignancies at the time of NEC diagnosis, except for non-invasive cancers like basal cell carcinoma or squamous cell carcinoma of the skin, or in situ cervical cancer.
- Patients or their legal representatives unwilling or unable to provide informed consent (if needed per ethics committee).
Key Trial Info
Start Date :
November 3 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT07192991
Start Date
November 3 2025
End Date
September 30 2026
Last Update
September 25 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.